1. Home
  2. CYBN vs NPWR Comparison

CYBN vs NPWR Comparison

Compare CYBN & NPWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYBN
  • NPWR
  • Stock Information
  • Founded
  • CYBN 2019
  • NPWR 2010
  • Country
  • CYBN Canada
  • NPWR United States
  • Employees
  • CYBN N/A
  • NPWR N/A
  • Industry
  • CYBN Pharmaceuticals and Biotechnology
  • NPWR Industrial Machinery/Components
  • Sector
  • CYBN Health Care
  • NPWR Energy
  • Exchange
  • CYBN Nasdaq
  • NPWR Nasdaq
  • Market Cap
  • CYBN 178.7M
  • NPWR 148.7M
  • IPO Year
  • CYBN N/A
  • NPWR N/A
  • Fundamental
  • Price
  • CYBN $7.54
  • NPWR $2.62
  • Analyst Decision
  • CYBN Strong Buy
  • NPWR Buy
  • Analyst Count
  • CYBN 4
  • NPWR 2
  • Target Price
  • CYBN $85.00
  • NPWR $4.00
  • AVG Volume (30 Days)
  • CYBN 412.3K
  • NPWR 2.0M
  • Earning Date
  • CYBN 08-12-2025
  • NPWR 08-11-2025
  • Dividend Yield
  • CYBN N/A
  • NPWR N/A
  • EPS Growth
  • CYBN N/A
  • NPWR N/A
  • EPS
  • CYBN N/A
  • NPWR N/A
  • Revenue
  • CYBN N/A
  • NPWR $250,000.00
  • Revenue This Year
  • CYBN N/A
  • NPWR $308.00
  • Revenue Next Year
  • CYBN N/A
  • NPWR $1,811.08
  • P/E Ratio
  • CYBN N/A
  • NPWR N/A
  • Revenue Growth
  • CYBN N/A
  • NPWR 100.00
  • 52 Week Low
  • CYBN $4.81
  • NPWR $1.48
  • 52 Week High
  • CYBN $13.88
  • NPWR $14.28
  • Technical
  • Relative Strength Index (RSI)
  • CYBN 46.24
  • NPWR 45.46
  • Support Level
  • CYBN $7.26
  • NPWR $2.68
  • Resistance Level
  • CYBN $7.81
  • NPWR $3.41
  • Average True Range (ATR)
  • CYBN 0.45
  • NPWR 0.28
  • MACD
  • CYBN -0.04
  • NPWR -0.04
  • Stochastic Oscillator
  • CYBN 17.72
  • NPWR 3.42

About CYBN Cybin Inc.

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.

About NPWR NET Power Inc.

NET Power Inc is a clean energy technology company that has developed a novel power generation system, which it refers to as the NET Power Cycle, designed to produce clean, reliable, and low-cost electricity from natural gas while capturing virtually all atmospheric emissions. The company's business model is to license its technology to customers and enable them to build, own, and operate facilities that utilize the Net Power Cycle. It has conducted a successful demonstration of its technology at the La Porte Demonstration Facility and is developing a utility-scale power plant in Texas named Project Permian.

Share on Social Networks: